Melanoma cells demonstrate high levels of expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 and high circulating serum levels of VEGF are associated with poor prognosis in patients with melanoma (19, 20). This evidence concerns the gene VEGFA and melanoma.